Literature DB >> 18989817

Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy.

Daisuke Hayashi1, Ryuji Kubota, Norihiro Takenouchi, Tomonori Nakamura, Fujio Umehara, Kimiyoshi Arimura, Shuji Izumo, Mitsuhiro Osame.   

Abstract

Human T-lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a slowly progressive, inflammatory disease of the central nervous system (CNS). We report a patient with transverse myelitis, who exhibited acute onset and rapid progression of the disease and whose symptoms resembled those observed in multiple sclerosis with spinal cord presentation. During neurological exacerbation of the condition, the HTLV-I proviral load in the cerebrospinal fluid (CSF) increased to 10 times that in the peripheral blood. This suggests that the accumulation of HTLV-I-infected cells in the CNS contributes to neurological exacerbation. Based on the increased proviral load in the CSF, we diagnosed the disease as acute progressive HAM/TSP. The measurement of the HTLV-I proviral load in the CSF is useful for the diagnosis of HAM/TSP and for monitoring its progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18989817     DOI: 10.1080/13550280802178538

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  16 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years.

Authors:  T Matsuzaki; M Nakagawa; M Nagai; K Usuku; I Higuchi; K Arimura; H Kubota; S Izumo; S Akiba; M Osame
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

3.  HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.

Authors:  M Nakagawa; S Izumo; S Ijichi; H Kubota; K Arimura; M Kawabata; M Osame
Journal:  J Neurovirol       Date:  1995-03       Impact factor: 2.643

4.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

6.  Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells.

Authors:  M Osame; M Matsumoto; K Usuku; S Izumo; N Ijichi; H Amitani; M Tara; A Igata
Journal:  Ann Neurol       Date:  1987-02       Impact factor: 10.422

7.  Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes.

Authors:  T Moritoyo; T A Reinhart; H Moritoyo; E Sato; S Izumo; M Osame; A T Haase
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

8.  HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy.

Authors:  R Kubota; F Umehara; S Izumo; S Ijichi; K Matsumuro; S Yashiki; T Fujiyoshi; S Sonoda; M Osame
Journal:  J Neuroimmunol       Date:  1994-08       Impact factor: 3.478

9.  Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy.

Authors:  Y Itoyama; J Kira; N Fujii; I Goto; N Yamamoto
Journal:  Ann Neurol       Date:  1989-08       Impact factor: 10.422

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  12 in total

1.  Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors:  Mineki Saito
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-10

2.  Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: the particular context of virus infection.

Authors:  Pascale Giraudon; Adeline Nicolle; Sylvie Cavagna; Claire Benetollo; Romain Marignier; Michel Varrin-Doyer
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

3.  HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.

Authors:  Keiko Yasuma; Toshio Matsuzaki; Yoshihisa Yamano; Hiroshi Takashima; Masao Matsuoka; Mineki Saito
Journal:  J Neurovirol       Date:  2015-12-03       Impact factor: 2.643

4.  HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter.

Authors:  Saifur Rahman; Kevin Quann; Devanshi Pandya; Shruti Singh; Zafar K Khan; Pooja Jain
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

5.  CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Tomoo Sato; Ariella Coler-Reilly; Atae Utsunomiya; Natsumi Araya; Naoko Yagishita; Hitoshi Ando; Junji Yamauchi; Eisuke Inoue; Takahiko Ueno; Yasuhiro Hasegawa; Kusuki Nishioka; Toshihiro Nakajima; Steven Jacobson; Shuji Izumo; Yoshihisa Yamano
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

6.  Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Eiji Matsuura; Ryuji Kubota; Yuetsu Tanaka; Hiroshi Takashima; Shuji Izumo
Journal:  J Neuropathol Exp Neurol       Date:  2015-01       Impact factor: 3.685

7.  Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB.

Authors:  Pooja Jain; Alfonso Lavorgna; Mohit Sehgal; Linlin Gao; Rashida Ginwala; Divya Sagar; Edward W Harhaj; Zafar K Khan
Journal:  Retrovirology       Date:  2015-02-27       Impact factor: 4.602

8.  Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives.

Authors:  Mineki Saito; Charles R M Bangham
Journal:  Leuk Res Treatment       Date:  2012-02-06

Review 9.  Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Mineki Saito
Journal:  J Neurovirol       Date:  2013-08-14       Impact factor: 3.739

10.  Relevance of retrovirus quantification in cerebrospinal fluid for neurologic diagnosis.

Authors:  Carolina Rosadas; Marzia Puccioni-Sohler
Journal:  J Biomed Sci       Date:  2015-08-08       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.